Top 10 Vaccines in 2013

 

#10 – Pneumovax
Pneumococcal infection
2013 – $653 million
2012 – $580 million
Marketed by Merck and Sanofi Pasteur MSD
#9 – RotaTeq
Rotaviral gastroenteritis
2013 – $691 million
2012 – $648 million
Marketed by Merck and Sanofi Pasteur MSD
#8 – Zostavax
Herpes Zoster (Shingles)
2013 – $826 million
2012 – $ N/A
Marketed by Merck and Sanofi Pasteur MSD
#7 – Hepatitis vaccine franchise
Hepatitis A, Hepatitis B
2013 – $984 million
2012 – $986 million
Marketed by GSK
#6 – Infanrix/Pediarix
Diptheria, Tetanus, Pertussis, Hepatitis B, Polio
2013 – $1.349 billion
2012 – $1.83 billion
Marketed by GSK

Top selling vaccines 2013 #5 to #1 >

Leave a Reply

Your email address will not be published. Required fields are marked *